- Home
- AGNC vs RVMD Comparison
AGNC vs RVMD Comparison
Compare AGNC & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGNC
- RVMD
- Stock Information
- Founded
- AGNC 2008
- RVMD 2014
- Country
- AGNC United States
- RVMD United States
- Employees
- AGNC N/A
- RVMD N/A
- Industry
- AGNC Real Estate Investment Trusts
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AGNC Real Estate
- RVMD Health Care
- Exchange
- AGNC Nasdaq
- RVMD Nasdaq
- Market Cap
- AGNC 8.9B
- RVMD 8.7B
- IPO Year
- AGNC 2008
- RVMD 2020
- Fundamental
- Price
- AGNC $10.54
- RVMD $41.33
- Analyst Decision
- AGNC Buy
- RVMD Strong Buy
- Analyst Count
- AGNC 10
- RVMD 13
- Target Price
- AGNC $10.50
- RVMD $65.15
- AVG Volume (30 Days)
- AGNC 20.2M
- RVMD 1.2M
- Earning Date
- AGNC 01-27-2025
- RVMD 02-26-2025
- Dividend Yield
- AGNC 13.66%
- RVMD N/A
- EPS Growth
- AGNC 1760.00
- RVMD N/A
- EPS
- AGNC 0.93
- RVMD N/A
- Revenue
- AGNC $973,000,000.00
- RVMD $742,000.00
- Revenue This Year
- AGNC N/A
- RVMD N/A
- Revenue Next Year
- AGNC N/A
- RVMD $1,855.56
- P/E Ratio
- AGNC $11.33
- RVMD N/A
- Revenue Growth
- AGNC 287.65
- RVMD N/A
- 52 Week Low
- AGNC $8.92
- RVMD $28.95
- 52 Week High
- AGNC $10.85
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- AGNC 76.62
- RVMD 44.66
- Support Level
- AGNC $10.05
- RVMD $40.13
- Resistance Level
- AGNC $10.17
- RVMD $42.68
- Average True Range (ATR)
- AGNC 0.12
- RVMD 1.41
- MACD
- AGNC 0.03
- RVMD 0.10
- Stochastic Oscillator
- AGNC 91.40
- RVMD 26.42
About AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.